ArticleFrontiers in cardiovascular medicine2026
Epicardial adipose tissue volume stratifies atrial fibrillation subtypes in reduced ejection fraction heart failure: a CT-based predictor.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Epicardial adipose tissue (EAT) is involved in atrial fibrillation (AF) pathogenesis. Its specific role in stratifying AF subtypes among patients who also have reduced ejection fraction heart failure is not well defined. Objective: We aimed to compare EAT volume between AF patients with and without reduced ejection fraction heart failure, and to assess its link with AF subtypes. Methods: In this retrospective study, 224 AF patients (2018-2023) were classified into CAH group (combined AF and heart failure, LVEF < 50%, Results: Overall EAT volume was similar between the CAH and AF groups (152.3 ± 61.6 vs. 166.8 ± 73.2 mL, Conclusion: In patients with heart failure, increased epicardial adipose tissue (EAT) volume is linked to the progression from paroxysmal to persistent atrial fibrillation (AF). Measuring EAT volume may therefore serve as a useful imaging biomarker to identify those at higher risk of AF progression, which could help guide more personalized management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.